Byron Lawson - 18 Aug 2022 Form 4 Insider Report for HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ)

Role
SVP/Chief Commercial Officer
Signature
/s/ Shaun D. McMeans, Attorney-in-Fact
Issuer symbol
HTGMQ
Transactions as of
18 Aug 2022
Transactions value $
$0
Form type
4
Filing time
22 Aug 2022, 17:51:23 UTC
Previous filing
01 Jul 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HTGMQ Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 18 Aug 2022 Common Stock 20,000 $0.9400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of eight (8) successive equal quarterly installments on the last day of each calendar quarter, with the first vesting to occur on September 30, 2022.